ArticleAntimicrobial agents and chemotherapy2013

Adapted J6/JFH1-based Hepatitis C virus recombinants with genotype-specific NS4A show similar efficacies against lead protease inhibitors, alpha interferon, and a putative NS4A inhibitor.

Judith M Gottwein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.